These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8607961)

  • 1. Duration of action of intranasal atropine on methacholine-induced nasal secretions.
    Baroody FM; Driscoll PV; Moylan B; Fleming L; Shilstone J; Naclerio RM
    Arch Otolaryngol Head Neck Surg; 1996 Mar; 122(3):321-3. PubMed ID: 8607961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions.
    Wagenmann M; Baroody FM; Jankowski R; Nadal JC; Roecker-Cooper M; Wood CC; Naclerio RM
    Clin Exp Allergy; 1994 Mar; 24(3):288-90. PubMed ID: 8012861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of loratadine and terfenadine on the induced nasal allergic reaction.
    Baroody FM; Lim MC; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    Arch Otolaryngol Head Neck Surg; 1996 Mar; 122(3):309-16. PubMed ID: 8607960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine.
    Baroody FM; Majchel AM; Roecker MM; Roszko PJ; Zegarelli EC; Wood CC; Naclerio RM
    J Allergy Clin Immunol; 1992 Jun; 89(6):1065-75. PubMed ID: 1535082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A time-dose study of the effect of topical ipratropium bromide on methacholine-induced rhinorrhoea in patients with perennial non-allergic rhinitis.
    Becker B; Borum S; Nielsen K; Mygind N; Borum P
    Clin Otolaryngol Allied Sci; 1997 Apr; 22(2):132-4. PubMed ID: 9160925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of nasal mucosa to histamine or methacholine challenge: use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide.
    Naclerio RM; Baroody FM
    J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 2):1051-4. PubMed ID: 1460207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
    Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes.
    Riccio MM; Proud D
    J Allergy Clin Immunol; 1996 Jun; 97(6):1252-63. PubMed ID: 8648021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cytokines in nasal secretions after nasal antigen challenge: lack of influence of antihistamines.
    Bensch GW; Nelson HS; Borish LC
    Ann Allergy Asthma Immunol; 2002 May; 88(5):457-62. PubMed ID: 12027065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal atropine sulfate: efficacy and safety of 0.050% and 0.075% solutions for severe rhinorrhea.
    Georgitis JW
    Arch Otolaryngol Head Neck Surg; 1998 Aug; 124(8):916-20. PubMed ID: 9708720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
    de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intranasal azelastine on the response to nasal allergen challenge.
    Saengpanich S; Assanasen P; deTineo M; Haney L; Naclerio RM; Baroody FM
    Laryngoscope; 2002 Jan; 112(1):47-52. PubMed ID: 11802037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine.
    Borum S; Nielsen K; Bisgaard H; Mygind N
    Rhinology; 1998 Dec; 36(4):153-5. PubMed ID: 9923056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal glandular secretory response to cholinergic stimulation in humans and guinea pigs.
    Gawin AZ; Emery BE; Baraniuk JN; Kaliner MA
    J Appl Physiol (1985); 1991 Dec; 71(6):2460-8. PubMed ID: 1778947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ipratropium bromide on nasal hypersecretion induced by methacholine in patients with vasomotor rhinitis. A double-blind, cross-over, placebo-controlled and randomized dose-response study.
    Sjögren I; Jonsson L; Köling A; Jansson C; Osterman K; Håkansson B
    Acta Otolaryngol; 1988; 106(5-6):453-9. PubMed ID: 2974675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
    Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo human models for the study of anticholinergic drugs.
    Naclerio RM; Baroody FM
    J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1069-79. PubMed ID: 7751524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the TRPV1 antagonist SB-705498 on the nasal parasympathetic reflex response in the ovalbumin sensitized guinea pig.
    Changani K; Hotee S; Campbell S; Pindoria K; Dinnewell L; Saklatvala P; Thompson SA; Coe D; Biggadike K; Vitulli G; Lines M; Busza A; Denyer J
    Br J Pharmacol; 2013 Jun; 169(3):580-9. PubMed ID: 23441756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal ipratropium: inhibition of methacholine induced hypersecretion.
    Borum P
    Rhinology; 1978 Dec; 16(4):225-33. PubMed ID: 154164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide metabolites in nasal lavage fluid of patients with house dust mite allergy.
    Garrelds IM; van Amsterdam JG; de Graaf-in't Veld C; Gerth van Wijk R; Zijlstra FJ
    Thorax; 1995 Mar; 50(3):275-9. PubMed ID: 7660342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.